Generic Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Global Generic Injectables Market is forecast to expand impressively at a CAGR of 13% during the forecast period 2021-2027. 

Generic injectables are the bioequivalents of branded products that are not protected by drug patents. It is as safe and effective as Innovator medicines because the active ingredients, dosage, strength, quality, and form are similar. Manufacturing generic injectables is complex, but R&D cycles are cheaper and shorter. Unlike brand-name drug manufacturers, who spend millions of dollars on R&D and marketing, generic drug manufacturers don’t need that kind of investment. In addition, since there are fewer competitors in the generic market for injectables compared to oral generics, price decline is limited and profitability is quite high.

Market Segments

By Product type       

• Monoclonal Antibodies Generic injectable
• Immunoglobulin Generic injectable
• Cytokines Generic injectable
• Insulin Generic injectable
• Peptide Hormones Generic injectable
• Blood Factors Generic injectable
• Peptide Antibiotics Generic injectable
• Vaccines Generic injectable
• Small Molecule Antibiotics Generic injectable
• Chemotherapy Agents Generic injectable

By Molecule Type

• Small Molecule Generic injectable
• Large Molecule Generic injectable

Key Players

• Samsung Biologics Co Ltd
• Aurobindo Pharma Limited
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Merck & Co. Inc.
• Cipla Ltd
• Pfizer Inc
• Fresenius Kabi

Scope of the Report

The research study analyzes the global Generic Injectables industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Generic Injectables Market Report

1. What was the Generic Injectables Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Generic Injectables Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Generic Injectables Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.